Skip to content

Biomakers

2 viewers · 30d

Total raised

$5.9M

1 filing since 2024 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $5.9M
ROUNDS
1
INVESTORS
7
FOUNDED
N/A
HQ
City Of Dover, County Of Kent, DE
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

BIOMAKERS is a precision oncology company that runs genomic and molecular testing for cancer patients and combines the results with clinical data, biobanking, and AI on a single platform. It operates clinical laboratories in Argentina, Brazil, and Mexico serving a network of thousands of physicians across Latin America, and is headquartered in San Francisco, California. Testing spans immunohistochemistry, FISH, real-time and digital PCR, and next-generation sequencing, and the company reports hundreds of thousands of genomic studies completed and a biobank of tumor samples. Alongside patient diagnostics, it sells the resulting real-world genomic and clinical data to life sciences companies for drug and diagnostic development.

What sets it apart

It pairs a Latin American clinical testing and biobanking footprint most global diagnostics companies do not have with an AI-native data layer, so the same infrastructure that returns a therapy recommendation to a treating physician also produces globally relevant real-world oncology data for drug developers.

Funding history

1 round
EquityJan 26, 2024
Form D/A
+$5.9M$5.9M total

Latest SEC filings

via EDGAR · CIK 0002010983
Form D/A · Jan 26, 2024View on EDGAR

Products

1 tracked

BIOMAKERS precision oncology platform

Molecular diagnostics

Genomic and molecular tumor profiling delivered through the company's own clinical laboratories, with results integrated into a platform that connects testing, clinical data, and biobanked specimens to support targeted therapy decisions.

  • Next-generation sequencing, PCR, FISH, and immunohistochemistry tumor profiling
  • Company-operated clinical laboratories in Argentina, Brazil, and Mexico
  • Bioinformatics analysis producing targeted therapeutic recommendations
  • AI layer linking genomic results with clinical data